Evidence map›Paper›PMID 31305512›Full record

ArticleJournal of visualized experiments : JoVE2019

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats.

Natia Q Kelm, Jason E Beare, Amanda J LeBlanc

Abstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Natia Q KelmCardiovascular Innovation Institute, University of Louisville; natia.kelm@louisville.edu.
Jason E BeareCardiovascular Innovation Institute, University of Louisville; Kentucky Spinal Cord Injury Research Center, University of Louisville.
Amanda J LeBlancCardiovascular Innovation Institute, University of Louisville; Department of Physiology, University of Louisville.

Funding

Reversing Microvascular Dysfunction in Advancing AgeR01AG053585 · NIA · UNIVERSITY OF LOUISVILLE · PI LEBLANC, AMANDA J · 2017 to 2021
$1.7M
NIA NIH HHS R01 AG053585
6 · The paper itself

Abstract

Coronary artery disease is the leading cause of death worldwide. After an acute myocardial infarction, early and successful myocardial intervention via recanalization of the coronary artery is the most effective strategy for reducing the size of ischemic myocardium. The coronary microvasculature cannot be visualized and imaged in vivo, but there are several invasive and noninvasive techniques that can be used to assess parameters which depend directly on coronary microvascular function. The endothelial function after ischemia reperfusion can be assessed also at the level of the coronary circulation via the coronary flow reserve (CFR). In this study, peak velocity of left anterior descending (LAD) coronary arteries was measured in rats in vivo via Transthoracic Doppler Echocardiography during resting and stress challenge (induced by Dobutamine). A normal heart can increase its coronary blood flow up to four times above the resting values during stress induction. Following ischemia reperfusion, we found a significantly diminished CFR, which can be used as a marker of coronary microvascular dysfunction. CFR has opened a window on the importance of microvascular dysfunction and has been shown to predict cardiovascular risk independent of whether the severe obstructive disease is present.

Indexed as

Myocardial ReperfusionAnimalsCoronary Artery DiseaseCoronary CirculationCoronary VesselsEchocardiography, DopplerFemaleMyocardial InfarctionMyocardial IschemiaRats

Identifiers

PMID31305512
PMCPMC6996202

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.